SMA Related Analyst Ratings
-
Northcoast Research Downgrades Symmetry Medical (SMA) to Neutral
-
Benchmark Starts Symmetry Medical (SMA) at Hold; Business in Transition
-
Northcoast Research Upgrades Symmetry Medical (SMA) to Buy
-
Northcoast Research Downgrades Symmetry Medical (SMA) to Neutral
-
Duncan-Williams Initiates Coverage on Symmetry Medical (SMA) with a Buy; Macro Defensive-Growth Characteristics
-
Piper Jaffray Upgrades Symmetry Medical (SMA) to Overweight; Shares Look Oversold
-
Wells Fargo Upgrades Symmetry Medical (SMA) to Market Perform; Cycle Has Bottomed
-
Sidoti & Co Starts Symmetry Medical (SMA) at Buy
-
Wachovia Upgrades Symmetry Medical (SMA) to Market Perform on Valuation
-
Matrix USA Rating Changes 8/27
-
Wachovia Downgrades Symmetry Medical (SMA) to Underperform
-
Wachovia Downgrades Symmetry Medical (SMA) to Market Perform
-
Piper Jaffray Transfers Coverage on a Number on Medical Equipment Makers
-
Wachovia upgrades Symmetry Medical (SMA) to Outperform
-
Matirx upgrades Symmetry Medical Inc (SMA) to Strong Buy
-
Wachovia Securities Downgrades Symmetry Medical (SMA) to Market Perform
-
Piper Jaffray Downgraded SMA
-
William Blair Started SMA at Outperform
-
CSFB Started SMA at Neutral
Back to SMA Stock Lookup
